TXNIP and type 2 diabetes mellitus: Although the decrease in TXNIP gene expression compared with placebo did not reach statistical significance, the findings suggest that verapamil may improve glycemic control in T2DM through downregulation of TXNIP expression and promotion of β-cell survival [50].